{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:32:48Z","timestamp":1763037168614},"reference-count":32,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"ACS-9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.14745\/ccdr.v36i00a09","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T14:52:34Z","timestamp":1520002354000},"page":"1-22","source":"Crossref","is-referenced-by-count":1,"title":["Statement on Measles-Mumps-Rubella-Varicella Vaccine"],"prefix":"10.14745","volume":"36","author":[{"given":"Ben","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shainoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5795","published-online":{"date-parts":[[2010,9]]},"reference":[{"key":"key20180302095221_r1"},{"key":"key20180302095221_r2","first-page":"1","article-title":"Statement on mumps vaccine","volume":"33","author":"National Advisory Committee on Immunization (NACI)","year":"2007","journal-title":"Can Commun Dis Rep"},{"key":"key20180302095221_r3","first-page":"1","article-title":"Update on varicella","volume":"30","author":"NACI","year":"2004","journal-title":"Can Commun Dis Rep"},{"key":"key20180302095221_r4","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"key20180302095221_r5","doi-asserted-by":"crossref","unstructured":"Campbell A, Tan B, Ismail S. Literature review on one and two dose varicella vaccination. PHAC. 2010. Available from: http:\/\/www.phac-aspc.gc.ca\/naci-ccni\/index-eng.php","DOI":"10.14745\/ccdr.v36i00a10"},{"issue":"3","key":"key20180302095221_r6","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","year":"2008","journal-title":"Pediatrics"},{"key":"key20180302095221_r7","article-title":"An Advisory Committee Statement (ACS). Varicella vaccination two-dose recommendations","author":"NACI","year":"2010","journal-title":"Can Commun Dis Rep"},{"issue":"6","key":"key20180302095221_r8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","article-title":"Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix)","volume":"22","year":"2008","journal-title":"BioDrugs"},{"issue":"8","key":"key20180302095221_r9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","article-title":"Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life","volume":"27","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"47","key":"key20180302095221_r10","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","year":"2009","journal-title":"Vaccine"},{"issue":"3-4","key":"key20180302095221_r11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine","volume":"21","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"key20180302095221_r12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"25","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"key20180302095221_r13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.inf.0000250689.09396.21","article-title":"Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years","volume":"26","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"key20180302095221_r14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","article-title":"Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age","volume":"35","year":"2007","journal-title":"Infection"},{"issue":"8","key":"key20180302095221_r15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00431-007-0506-z","article-title":"Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months","volume":"166","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"3","key":"key20180302095221_r16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.vaccine.2008.10.064","article-title":"Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine","volume":"27","year":"2009","journal-title":"Vaccine"},{"issue":"20","key":"key20180302095221_r17","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.vaccine.2009.02.044","article-title":"Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"key20180302095221_r18"},{"key":"key20180302095221_r19"},{"key":"key20180302095221_r20"},{"key":"key20180302095221_r21"},{"key":"key20180302095221_r22","first-page":"1","article-title":"Varizig as the varicella zoster immune globulin for the prevention of varicella in at-risk patients","volume":"32","author":"NACI","year":"2006","journal-title":"Can Commun Dis Rep"},{"issue":"8","key":"key20180302095221_r23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006","volume":"28","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"key20180302095221_r24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00431-010-1142-6","article-title":"Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months","volume":"169","year":"2010","journal-title":"Eur J Pediatr"},{"issue":"6","key":"key20180302095221_r25","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","article-title":"Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months","volume":"29","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"key20180302095221_r26","first-page":"110","article-title":"Childhood febrile seizures: overview and implications","volume":"4","year":"2007","journal-title":"Int J Med Sci"},{"issue":"2","key":"key20180302095221_r27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1067\/mem.2003.48","article-title":"Evaluation and management of febrile seizures in the out-of-hospital and emergency department settings","volume":"41","year":"2003","journal-title":"Ann Emerg Med"},{"issue":"10","key":"key20180302095221_r28","first-page":"258","article-title":"Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"key20180302095221_r29","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"key20180302095221_r30"},{"issue":"3","key":"key20180302095221_r31","first-page":"207","article-title":"New grades for recommendations from the Canadian Task Force on Preventive Health Care","volume":"169","author":"Canadian Task Force on Preventive Health Care","year":"2003","journal-title":"CMAJ"},{"issue":"3","key":"key20180302095221_r32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20","author":"Methods Work Group, Third US Preventive Services Task Force","year":"2001","journal-title":"Am J Prev Med"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/10pdf\/36-acs-9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T04:54:01Z","timestamp":1570856041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/10pdf\/36-acs-9.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":32,"journal-issue":{"issue":"ACS-9","published-online":{"date-parts":[[2010,9]]},"published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v36i00a09","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}